1 Min Read
Feb 15 (Reuters) - Jerusalem Pharmaceuticals Co:
* FY net profit after tax $3.2 million versus $2.2 million year ago
* FY sales $28.6 million versus $28.7 million year ago Source: (bit.ly/2kScN9A) Further company coverage: )
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.